Expression patterns of progesterone receptor membrane components 1 and 2 in endometria from women with and without endometriosis

Reproductive Sciences

Volumn 21, Issue 2, 2014, Pages 190-197

  Bunch, Kristen ^a   Tinnemore, Deborah ^a   Huff, Seth ^a   Hoffer, Zachary S ^a   Burney, Richard O ^a   Stallings, Jonathan D ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

endometriosis; PGRMC 1; PGRMC 2; progesterone; progesterone receptor membrane component 1; progesterone receptor membrane component 2

Indexed keywords

ESTRADIOL; PEROXIDASE; PROGESTERONE; PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1; PROGESTERONE RECEPTOR MEMBRANE COMPONENT 2; SEX HORMONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME ACTIVITY; ESTRADIOL BLOOD LEVEL; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETROSPECTIVE STUDY; STROMA CELL;

ENDOMETRIOSIS; PGRMC-1; PGRMC-2; PROGESTERONE; PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1; PROGESTERONE RECEPTOR MEMBRANE COMPONENT 2;

ADULT; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE PROTEINS; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 84892964177     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719113492208     Document Type: Article

References (32)

1. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am. 1997 ; 24 (2). 235-258
2. Bulun SE. Endometriosis. N Engl J Med. 2009 ; 360 (3). 268-279
3. Graham JD, Clarke CL. Physiological action of progesterone in target tissues. Endocr Rev. 1997 ; 18 (4). 502-519
4. Maruyama T, Yoshimura Y. Molecular and cellular mechanisms for differentiation and regeneration of the uterine endometrium. Endocr J. 2008 ; 55 (5). 795-810
5. Burney RO, Talbi S, Hamilton AE, et al. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology. 2007 ; 148 (8). 3814-3826
6. Igarashi TM, Bruner-Tran KL, Yeaman GR, et al. Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fertil Steril. 2005 ; 84 (1). 67-74
7. Wierman ME. Sex steroid effects at target tissues: mechanisms of action. Adv Physiol Educ. 2007 ; 31 (1). 26-33
8. Gellersen B, Fernandes MS, Brosens JJ. Non-genomic progesterone actions in female reproduction. Hum Reprod Update. 2009 ; 15 (1). 119-138
9. Losel RM, Falkenstein E, Feuring M, et al. Nongenomic steroid action: controversies, questions, and answers. Physiol Rev. 2003 ; 83 (3). 965-1016
10. Gerdes D, Wehling M, Leube B, Falkenstein E. Cloning and tissue expression of two putative steroid membrane receptors. Biol Chem. 1998 ; 379 (7). 907-911
11. Falkenstein E, Meyer C, Eisen C, Scriba PC, Wehling M. Full-length cDNA sequence of a progesterone membrane-binding protein from porcine vascular smooth muscle cells. Biochem Biophys Res Commun. 1996 ; 229 (1). 86-89
12. Meyer C, Schmid R, Scriba PC, Wehling M. Purification and partial sequencing of high-affinity progesterone-binding site(s) from porcine liver membranes. Eur J Biochem. 1996 ; 239 (3). 726-731
13. Rohe HJ, Ahmed IS, Twist KE, Craven RJ. PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding. Pharmacol Ther. 2009 ; 121 (1). 14-19
14. Zhang L, Kanda Y, Roberts DJ, et al. Expression of progesterone receptor membrane component 1 and its partner serpine 1 mRNA binding protein in uterine and placental tissues of the mouse and human. Mol Cell Endocrinol. 2008 ; 287 (1-2). 81-89
15. Talbi S, Hamilton AE, Vo KC, et al. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology. 2006 ; 147 (3). 1097-1121
16. Chen JI, Hannan NJ, Mak Y, et al. Proteomic characterization of midproliferative and midsecretory human endometrium. J Proteome Res. 2009 ; 8 (4). 2032-2044
17. Keator CS, Mah K, Slayden OD. Alterations in progesterone receptor membrane component 2 (PGRMC2) in the endometrium of macaques afflicted with advanced endometriosis. Mol Hum Reprod. 2012 ; 18 (6). 308-319
18. Crudden G, Loesel R, Craven RJ. Overexpression of the cytochrome p450 activator hpr6 (heme-1 domain protein/human progesterone receptor) in tumors. Tumour Biol. 2005 ; 26 (3). 142-146
19. Peluso JJ, Liu X, Gawkowska A, Johnston-MacAnanny E. Progesterone activates a progesterone receptor membrane component 1-dependent mechanism that promotes human granulosa/luteal cell survival but not progesterone secretion. J Clin Endocrinol Metab. 2009 ; 94 (7). 2644-2649
20. Neubauer H, Clare SE, Wozny W, et al. Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1. Breast Cancer Res. 2008 ; 10 (5). R85
21. Cahill MA. Progesterone receptor membrane component 1: an integrative review. J Steroid Biochem Mol Biol. 2007 ; 105 (1-5). 16-36
22. Causey MW, Huston LJ, Harold DM, et al. Transcriptional analysis of novel hormone receptors PGRMC1 and PGRMC2 as potential biomarkers of breast adenocarcinoma staging. J Surg Res. 2011 ; 171 (2). 615-622
23. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol. 1975 ; 122 (2). 262-263
24. Barash Y, Calarco JA, Gao W, et al. Deciphering the splicing code. Nature. 2010 ; 465 (7294). 53-59
25. Klein M, Vignaud JM, Hennequin V, et al. Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma. J Clin Endocrinol Metab. 2001 ; 86 (2). 656-658
26. Kao LC, Germeyer A, Tulac S, et al. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology. 2003 ; 144 (7). 2870-2881
27. Bulun SE, Cheng YH, Yin P, et al. Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol. 2006 ; 248 (1-2). 94-103
28. Ace CI, Okulicz WC. Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phase. Reprod Biol Endocrinol. 2004 ; 2: 54
29. Aghajanova L, Hamilton A, Kwintkiewicz J, Vo KC, Giudice LC. Steroidogenic enzyme and key decidualization marker dysregulation in endometrial stromal cells from women with versus without endometriosis. Biol Reprod. 2009 ; 80 (1). 105-114
30. Attia GR, Zeitoun K, Edwards D, Johns A, Carr BR, Bulun SE. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab. 2000 ; 85 (8). 2897-2902
31. Zeitoun K, Takayama K, Sasano H, et al. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab. 1998 ; 83 (12). 4474-4480
32. Peluso JJ. Multiplicity of progesterone's actions and receptors in the mammalian ovary. Biol Reprod. 2006 ; 75 (1). 2-8